mct

α-Cyano-4-hydroxycinnamic acid (α-Cyano-4-hydroxycinnamic acid(α-CHCA)) 是非竞争性单羧酸盐转运蛋白 (MCTs) 抑制剂，可抑制线粒体丙酮酸转运蛋白，Ki 值为 6.3 μM。它可作为基质辅助激光解吸电离-飞行时间质谱 (MALDI-TOF) 分析的基质，可以促进肽离子化。

SR13800 is a monocarboxylate transporter 1 (MCT1) inhibitor with cell-permeable.

MCT-IN-1 (compound 2) 作为单羧酸转运蛋白 (monocarboxylate transporter(MCT)) 的抑制剂表现有效，其对MCT1和MCT4的抑制浓度IC50分别达到9 nM及14 nM。

MCT1-IN-3是一种单羧酸转运蛋白1 (MCT1)抑制剂。溶质载体(SLC)单羧酸转运蛋白1 (MCT1);SLC16A1)是治疗癌症的一个有希望的靶点。MCT1-IN-3(化合物24)对MCT1转运抑制作用强，IC50值为81.0 nM。MCT1-IN-3对多药转运体ABCB1也有明显的抑制作用。

MSC-4381 (MCT4-IN-1) 是一种可口服且具有选择性高效性的单羧酸转运蛋白 4 (MCT4/SLC16A3) 抑制剂，具有潜在的抗癌抗肿瘤活性，可用于研究骨肉瘤。

Tempoacmcta is a peptide.

Maresin conjugates in tissue regeneration 1 (MCTR1) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages at the site of inflammation. DHA is oxidized to maresin 1 , which is then converted to MCTR1 by glutathione S-transferase Mu 4 or leukotriene C4 synthase. MCTR1 accelerates tissue regeneration in planaria (1 and 100 nM). Pretreatment with MCTR1 (50 ng/mouse, i.p.) prior to E. coli administration reduces neutrophil infiltration, shortens the inflammatory resolution period, and increases phagocytosis of E. coli by macrophages. When administered at a dose of 100 ng 12h post E. coli infection in a mouse model of peritonitis, MCTR1 reduces the amount of eicosanoids in the exudate.

Maresin conjugates in tissue regeneration 2 (MCTR2) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages at the site of inflammation. DHA is oxidized to maresin 1 , which is converted to MCTR1 by glutathione S-transferase Mu 4 or leukotriene C4 synthase then to MCTR2 by γ-glutamyl transferase. MCTR2 accelerates tissue regeneration in planaria (1 and 100 nM). Pretreatment with MCTR2 prior to E. coli administration reduces neutrophil infiltration, shortens the inflammatory resolution period, and increases phagocytosis of E. coli by macrophages. When administered at a dose of 100 ng 12h post E. coli infection in a mouse model of peritonitis, MCTR2 selectively reduced the amount of the eicosanoids PGD2 and PGF2α in the exudate.

Maresin conjugates in tissue regeneration 3 (MCTR3) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages. DHA is oxidized to maresin 1 , which is converted to MCTR1 by glutathione S-transferase Mu 4 or leukotriene C4 synthase, then to MCTR2 by γ-glutamyl transferase, and to MCTR3 by dipeptidase. MCTR3 accelerates tissue regeneration in planaria (1 and 100 nM) approximately as potently as MCTR2 and more potently than MCTR1. Pretreatment with MCTR3 prior to E. coli administration in mice reduces neutrophil infiltration, shortens the inflammatory resolution period, and increases phagocytosis of E. coli by macrophages. When administered at a dose of 100 ng 12h post E. coli infection in a mouse model of peritonitis, MCTR3 selectively reduces the amount of the eicosanoids PGD2 , PGE2 , PGF2α , and TXB2 in the exudate.

IMCTA-C14是一种洗涤剂且是微生物代谢产物4-糖腺苷的衍生物。其临界胶束浓度(CMC)为0.11 mM，亲水亲油平衡(HLB)值为9.72。IMCTA-C14（0.05%和0.5%）能从OVK18卵巢癌细胞提取蛋白质，包括膜蛋白。它对几种不同菌株具有活性（MICs = 8-128 µg/ml），并对52种癌细胞系具有细胞毒性（IC50s = 2.9-29.2 µg/ml）。IMCTA-C14（50 µM）诱导OVK18细胞的自噬。

AZD3965 (AZD-3965) 是单羧酸转运蛋白 1 (MCT1) 的选择性抑制剂，Ki 值为1.6 nM，比 MCT2的选择性高6倍。

AR-C155858 是单羧酸转运蛋白 MCT1 和 MCT2 的抑制剂，Ki 分别为2.3和 10 nM。

m-C-tri(CH2-PEG1-NHS ester) is a non-cleavable one-unit polyethylene glycol (PEG) linker employed for the synthesis of antibody-drug conjugates (ADCs)[1].

PSMA617-TCMC is a derivative of PSMA-617 with structure modification, in which the caroboxy groups in DOTA ring is replaced by TCMC macrocycle. PSMA-617 is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer.

Boc-LRR-AMC TFA 是一种荧光蛋白酶底物，可检测 26S 蛋白酶体或 20S 蛋白酶核心的胰蛋白酶样活性。

BAY-8002 是一种可口服的单羧酸转运蛋白第 1 亚型 MCT1 选择性抑制剂，在表达 MCT1 的 DLD-1 细胞中，IC50值为 85 nM，具有抗肿瘤活性。

VB124 是一种具有口服活性的、有效且选择性的MCT4抑制剂。VB124 阻断了MDA-MB-231 细胞中的乳酸输入 (IC50值为8.6 nM) 和输出 (IC50值为19 nM)，VB124 对 MCT4 的选择性高于 MCT1，在表达 MCT1 的 BT20 细胞中显示出极小的 MCT1 抑制活性（IC50值为24 μM）。

H-β-Ala-AMC TFA 是氨基肽酶的底物之一。

AZD0095是 MCT4的选择性抑制剂，IC50为1.3 nM。

N-CBZ-Phe-Arg-AMC TFA (Z-FR-AMC TFA)是一种丝氨酸蛋白酶的荧光底物，被蛋白酶切割后放出游离的AMC，其激发/发射波长=380/460 nM,可用于评估胰蛋白酶、纤溶酶、组织蛋白酶的活性。

Pyr-Arg-Thr-Lys-Arg-AMC TFA为AMC肽类化合物，其结构由十肽组成，可经由特异性水解反应由如胰蛋白酶及凝血酶等蛋白酶作用下分解。该肽用于评估蛋白酶活性及酶抑制剂功效的检测。

Z-Gly-Gly-Arg-AMC TFA (66216-78-2 free base) 是一种凝血酶特异性荧光底物，用于检测 PRP 和贫血小板血浆 (PPP) 中的凝血酶生成。

MC-Thailanstatin A 为Drug-Linker 偶联物，主要用于ADC的合成。

GW604714X (2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]-) 是一种高度特异性的线粒体丙酮酸载体抑制剂，Ki<0.1 nM。它是一种线粒体呼吸抑制剂。它也能抑制质膜单羧酸转运体的 L-乳酸转运，但浓度比 MPC 的大 4 个数量级。